AzTrials
AzTrials

Early Pregnancy LossMISC-TRAINNCT06647849

Interest of Simulation Training on the Announcement of Early Pregnancy Loss on the Psychological Impact of the Patients

A study testing centers whose interns receive simulation training in the announcement of early spontaneous miscarriage between the 2 inclusion phases and centers with standard in-house management of spontaneous miscarriage/pregnancy arrested in the emergency department in people with Early Pregnancy Loss and Spontaneous Miscarriage, run by University Hospital, Angers at 28 sites in France.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Early pregnancy loss (or spontaneous miscarriage) is the loss of a pregnancy before 14 weeks of amenorrhea. Its incidence is estimated at between 10 and 15%, and increases with maternal age. Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Early Pregnancy Loss, Spontaneous Miscarriage
What is being tested?
centers whose interns receive simulation training in the announcement of early spontaneous miscarriage between the 2 inclusion phases and centers with standard in-house management of spontaneous miscarriage/pregnancy arrested in the emergency department
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
607 participants
Where
28 sitesFrance
Study dates
11 Nov 2024to 11 Jun 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adult patient
  • Patient presenting to gynaecological emergency department
  • Patient with a diagnosis of terminated pregnancy or spontaneous expulsion of a pregnancy < 14 weeks' amenorrhea
  • Patient whose spontaneous miscarriage was announced by an intern
  • Patient affiliated to or benefiting from a social security scheme
  • Patient having signed an informed consent form

Who cannot join

  • Unwanted pregnancy
  • Spontaneous hemorrhagic miscarriage requiring surgical management
  • Ectopic pregnancy
  • Miscarriage resulting from assisted reproduction treatment
  • Patient with history of miscarriage ≥ 3
  • Poor understanding of the French language
Show all 10Show fewer
  • Person deprived of liberty by judicial or administrative decision
  • Person under forced psychiatric care
  • Person subject to a legal protection measure
  • Person unable to give consent

Trial locations and contacts

28 sites in 1 country.

28 sites in 1 country

France28 sites
  • University Hospital of Amiens

    Amiens

  • University Hospital of Angers

    Angers

  • University Hospital of Bordeaux

    Bordeaux

  • University Hospital of Brest

    Brest

  • Femme Mere Enfant Hospital

    Bron

  • University Hospital of Caen

    Caen

  • CH Chalon-sur-Saône

    Chalon-sur-Saône

  • CH Cholet

    Cholet

  • University Hospital of Clermont-Ferrand

    Clermont-Ferrand

  • University Hospital of Dijon

    Dijon

  • CHU Grenoble

    Grenoble

  • Vendée Departmental Hospital center

    La Roche-sur-Yon

  • Le Mans Hospital

    Le Mans

  • Jeanne de Flandre Hospital

    Lille

  • University Hospital of Limoges

    Limoges

  • Hopital Nord (Marseille Public University Hospital System)

    Marseille

  • La Conception Hospital (Marseille Public University Hospital System)

    Marseille

  • University Hospital of Montpellier

    Montpellier

  • University Hospital of Nancy

    Nancy

  • University Hospital of Nantes

    Nantes

  • CHU Nice

    Nice

  • University Hospital of Nimes

    Nîmes

  • CHU Orléans

    Orléans

  • Poissy intercommunal hospital center

    Poissy

  • University Hsopital of Reims

    Reims

  • University Hospital of Rennes

    Rennes

  • University Hospital of Rouen

    Rouen

  • University Hospital of Saint Etienne

    Saint-Etienne

Other trials in France

About this study

Early pregnancy loss (or spontaneous miscarriage) is the loss of a pregnancy before 14 weeks of amenorrhea. Its incidence is estimated at between 10 and 15%, and increases with maternal age.

Early pregnancy loss can have major psychological consequences for the woman, her partner and the couple in the aftermath, as well as on the experience and progress of a future pregnancy.

Read more

In France, the vast majority of miscarriages are diagnosed in gynecological emergencies by interns still in training. Interns, sometimes at the beginning of their training, may find it difficult to announce a miscarriage, and may do so in a way that is clumsy or not adapted to the woman's emotions, which can lead to a bad experience for her. This bad experience could lead to psychological distress, post-traumatic stress and/or impair future fertility.

The initiators of this project have already carried out a before-and-after, single-center study, showing a significant improvement in the specific Perinatal Grief Scale score following specific training for interns in first-trimester pregnancy loss.

To date, no multicenter randomized study has been conducted to assess the impact of first-trimester pregnancy loss on women's psychological experience.

Being tested
centers whose interns receive simulation training in the announcement of early spontaneous miscarriage between the 2 inclusion phases, centers with standard in-house management of spontaneous miscarriage/pregnancy arrested in the emergency department
Keywords
spontaneous miscarriage, early pregnancy loss, training for interns
Medical subject headings
Abortion, Spontaneous

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • centers whose interns receive simulation training in the announcement of early spontaneous miscarriage between the 2 inclusion phasesProcedure or surgery

    The simulation training sessions for the announcement consultation are set up directly in the centers participating in the "with training" arm of the study, after the first phase of patient inclusion. These sessions will take place "in situ" in the center's maternity ward, and will be run by a single team trained in simulation and announcement.

    This team of trainers is identical for all centers randomized in the "with training" arm, and is made up of two trainers: an obstetrician-gynecologist and a psychologist.

  • centers with standard in-house management of spontaneous miscarriage/pregnancy arrested in the emergency departmentOther

    In the participating centers included in the "no training" arm, interns will have no specific training in announcement. Patients will receive information concerning the diagnosis of a terminated pregnancy or miscarriage from interns not trained in simulation.

    During the course of the study, training in the announcement of a miscarriage will be offered to interns from centers in the "no training" group.

Study groups in NCT06647849
Study groupRoleWhat they receive
Arm "with training"ExperimentalArm "with training": centers whose interns receive simulation training in the announcement of early spontaneous miscarriage between the 2 inclusion phases.
Receives: Procedure: centers whose interns receive simulation training in the announcement of early spontaneous miscarriage between the 2 inclusion phases
"Untrained" armOther"Untrained" arm: centers with standard in-house management of spontaneous miscarriage/pregnancy arrested in the emergency department.
Receives: Other: centers with standard in-house management of spontaneous miscarriage/pregnancy arrested in the emergency department

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. evaluate the impact of specific training for interns in simulated early miscarriage announcements on patients' psychological experiences

    Measured: The primary endpoint was the significant change in the Perinatal Grief Scale at 3 months post-miscarriage linked to the implementation of the simulation training

Secondary outcomes (6)
  1. Evaluation of the impact on the psychological experience of short-term miscarriage at 1 month

    Measured: Modification of the "Impact of event scale-revised" post-traumatic stress score at 1 month

  2. evaluation of the patient's feelings about the miscarriage announcement made by the intern at 1 month

    Measured: Modification of the patient's perception of the announcement of the miscarriage by the resident, using a 1-month questionnaire

  3. Assessing the impact of long-term miscarriage on psychological experience

    Measured: Modification in the Perinatal Grief Scale score at 6 and 12 months post-miscarriage linked to the introduction of simulated announcement training

  4. Fertility assessment at 6 and 12 months

    Measured: Time to decision to have a new pregnancy and increase in clinical pregnancy rates, progressive pregnancy rates > 14 weeks' amenorrhea at 6 and 12 months

  5. Comparing the difference of " Impact of event scale-revised" score in patients depending on whether they are cared for by an intern whose most recent training in prognosis was less than or more than 6 months ago

    Measured: 18 months

  6. Comparing the difference of " Impact of event scale-revised" score in patients depending on whether they were cared for by an intern who had received a single training course less than 6 months old, or by an intern who had received two training courses

    Measured: 18 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Oct 2024
  2. Study start11 Nov 2024
  3. Primary completion11 Jun 2027 (estimated)
  4. Study completion11 Jun 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
607 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06647849
Sponsor's protocol ID
49RC21_0257
Other IDs
2024-A01244-43
Acronym
MISC-TRAIN
Status last verified
Jun 2026
First submitted
9 Oct 2024
Last updated
25 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing centers whose interns receive simulation training in the announcement of early spontaneous miscarriage between the 2 inclusion phases and centers with standard in-house management of spontaneous miscarriage/pregnancy arrested in the emergency department in people with Early Pregnancy Loss and Spontaneous Miscarriage, run by University Hospital, Angers at 28 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 25 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 28 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

evaluate the impact of specific training for interns in simulated early miscarriage announcements on patients' psychological experiences (time frame: The primary endpoint was the significant change in the Perinatal Grief Scale at 3 months post-miscarriage linked to the implementation of the simulation training). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in